FASLG and breast carcinoma: The up-regulated lncRNAs included lncRNAs involved in chemotherapy resistance (MIR100HG and MGC32805) (35, 36) and tumorigenesis promoters (AC011632.1 and LINC00355) (37, 38), while down-regulated genes included MAGI2-AS3, an inhibiting factor of breast cancer cell growth via the Fas/FasL signaling pathway (39).